These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 644994)

  • 41. [Antacids and peptic ulcer].
    Vianello F; Di Mario F; Naccarato R
    G Clin Med; 1990 Feb; 71(2):123-6, 129-31. PubMed ID: 2189774
    [No Abstract]   [Full Text] [Related]  

  • 42. Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
    Namiot DB; Namiot Z; Kemona A; Bucki R; Gotebiewska M
    Helicobacter; 2007 Feb; 12(1):63-7. PubMed ID: 17241303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current aspects of course treatment and secondary prevention of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1990 Apr; 68(4):134-42. PubMed ID: 1973467
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of the functional state of the hepatobiliary system in the dynamics of treatment of patients with peptic ulcer].
    Vakhrushev IaM; Mufazdalova IV
    Eksp Klin Gastroenterol; 2005; (2):44-8. PubMed ID: 15932154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New developments in the treatment of peptic ulcer].
    Kapitanenko AM; Karnaukhov IuN
    Voen Med Zh; 1988 May; (5):37-9. PubMed ID: 3176377
    [No Abstract]   [Full Text] [Related]  

  • 48. [Changes in stomach and liver function in peptic ulcer in the course of treating it with the anabolic steroid preparation nerobol].
    Verevkin AM; Pevchikh VV
    Ter Arkh; 1972 May; 44(5):36-40. PubMed ID: 5069072
    [No Abstract]   [Full Text] [Related]  

  • 49. [Characteristics of the functional-morphological state of the gastroduodenal system in peptic ulcer associated with cholecystitis].
    Samson EI; Chernobrovyĭ VN; Maliukh LS; Gaĭdichuk SF; Kalugin VA
    Ter Arkh; 1978; 50(7):132-6. PubMed ID: 715712
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative efficacy of various pharmacotherapeutic agents in peptic ulcer].
    Burchinskiĭ GI; Kushnir VE; Reĭngardt BK
    Vrach Delo; 1968 Jul; 7():4-7. PubMed ID: 4392391
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of the antioxidant dibunol for the local treatment of gastroduodenal ulcers].
    Korochkin IM; Poslavskiĭ MV
    Sov Med; 1983; (12):102-4. PubMed ID: 6673136
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of acute and non-healing gastroduodenal ulcers with Gastrozol glue in ambulatory care].
    Strel'nikov BE; Krasnykh AM
    Klin Med (Mosk); 1983 Oct; 61(10):101-3. PubMed ID: 6645312
    [No Abstract]   [Full Text] [Related]  

  • 53. [Risk factor Helicobacter pylori. Prevention of stomach carcinoma].
    MMW Fortschr Med; 2005 May; 147(20):53. PubMed ID: 15957864
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
    Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
    Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
    Lux G
    Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
    [No Abstract]   [Full Text] [Related]  

  • 57. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 58. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of azafen on an experimental model of peptic ulcer].
    Kanishchev PA; Pereviazka AV
    Farmakol Toksikol; 1988; 51(1):37. PubMed ID: 3360104
    [No Abstract]   [Full Text] [Related]  

  • 60. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
    Takemoto T; Yanai H
    Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.